Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies. - Sasi BK; Tarantelli C; Martindale S; Civanelli E; Cannas E; Sartori G; Arribas AJ; Fernandes SM; Shupe SJ; Machado JH; Tyekucheva S; Ren Y; et al. (Haematologica, 2025)